A resource of validated and annotated gene fusions in cancer cell lines
In cancer cells, when two different genes are rearranged and joined, a fusion gene results and can act as a tumour driver. While many programs to predict fusion transcripts based on RNA-sequencing data do exist, the predictions contain many false positives without underlying genomic rearrangements. With the release of a new fusion validation pipeline to address this shortcoming, we have created a